Superficial radiation therapy treatment provides a non-surgical option for patients with basal cell carcinoma, squamous cell carcinoma, and keloid scarring. In this webcast, Dr. Colin Dicks, Radiation Oncologist from Just Skin in Australia, describes more about the treatment modality and how he targets skin cancer. He reviews patient selection criteria, presents several cases and outcomes, and describes how X-ray therapy is faster and more affordable than other treatment options. Just Skin is the leading superficial radiation therapy clinic in Australia, treating patients across three centers using Xstrahl equipment.
XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
